Dr. Herbert D. Aronow, M.D.
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- University of Michigan Medical School (1994)
- Years since graduation
- 32
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 101
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1994Medical school: University of Michigan Medical School
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
MI license 4301063695 -
Cardiovascular Disease Physician
MI license 4301063695
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Henry Ford Health Hospital Detroit, MI
- Henry Ford Health West Bloomfield Hospital W Bloomfield, MI
Medical groups
- Henry Ford Health System (2,570 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 101
- Services billed
- 327
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 40 | 38 |
| Established patient office or other outpatient visit, 40-54 minutes | 28 | 20 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 20 | 19 |
| New patient office or other outpatient visit, 45-59 minutes | 12 | 12 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 12 | 11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Ypsilanti, MI | 48 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Ypsilanti, MI | 18 |
| Ezetimibe Other prescribers in Ypsilanti, MI | 18 |
| Metoprolol Succinate Other prescribers in Ypsilanti, MI | 12 |
| Rosuvastatin Calcium Other prescribers in Ypsilanti, MI | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 17 payments worth $10,863 in total to this clinician.
| Recor Medical Inc | $5,004 |
|---|---|
| Novartis Pharmaceuticals Corporation | $3,238 |
| Medtronic, Inc. | $2,570 |
| Zoll Services LLC (a/k/a Zoll Lifecor Corp) | $38.05 |
| Abbott Laboratories | $14.36 |
| Consulting Fee | $7,638 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $2,675 |
| Food and Beverage | $505 |
| Travel and Lodging | $45.90 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation Aug 29, 2025 | Consulting Fee | $3,238 |
| Medtronic, Inc. Oct 6, 2025 | Compensation for services other than consulting (speaking, faculty) SYMPLICITY G3 · Renal Denervation System | $2,400 |
| Recor Medical Inc Jun 11, 2025 | Consulting Fee Paradise Ultrasound Renal Denervation System · Devices | $2,200 |
| Recor Medical Inc Nov 19, 2025 | Consulting Fee Paradise Ultrasound Renal Denervation System · Devices | $1,375 |
| Recor Medical Inc Nov 19, 2025 | Consulting Fee Paradise Ultrasound Renal Denervation System · Devices | $825 |
| Recor Medical Inc Apr 16, 2025 | Compensation for services other than consulting (speaking, faculty) Paradise Ultrasound Renal Denervation System · Devices | $275 |
| Recor Medical Inc Nov 19, 2025 | Travel and Lodging Paradise Ultrasound Renal Denervation System · Devices · travel to San Francisco, CA | $45.90 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $118,618 in research payments for these studies, mostly to the institutions running them.
- SPYRAL AFFIRM
Medtronic, Inc. - The THOR IDE Study
Philips North America LLC · Recruiting · NCT05916950
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.